120 related articles for article (PubMed ID: 1795436)
21. Plasma concentrations of apolipoprotein A-I containing particles in normolipidaemic young men.
Luc G; Parra HJ; Zylberberg G; Fruchart JC
Eur J Clin Invest; 1991 Feb; 21(1):118-22. PubMed ID: 1830842
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein-mediated cellular cholesterol/phospholipid efflux and plasma high density lipoprotein level in mice.
Tsujita M; Tomimoto S; Okumura-Noji K; Okazaki M; Yokoyama S
Biochim Biophys Acta; 2000 May; 1485(2-3):199-213. PubMed ID: 10832100
[TBL] [Abstract][Full Text] [Related]
23. High prebeta1-HDL levels in hypercholesterolemia are maintained by probucol but reduced by a low-cholesterol diet.
Miida T; Yamaguchi T; Tsuda T; Okada M
Atherosclerosis; 1998 May; 138(1):129-34. PubMed ID: 9678778
[TBL] [Abstract][Full Text] [Related]
24. Hyperthyroidism influences the distribution and apolipoprotein A composition of the high density lipoproteins in man.
Muls E; Rosseneu M; Bury J; Stul M; Lamberigts G; De Moor P
J Clin Endocrinol Metab; 1985 Nov; 61(5):882-9. PubMed ID: 3930554
[TBL] [Abstract][Full Text] [Related]
25. Lipid-free apolipoprotein (apo) A-I is converted into alpha-migrating high density lipoproteins by lipoprotein-depleted plasma of normolipidemic donors and apo A-I-deficient patients but not of Tangier disease patients.
von Eckardstein A; Huang Y; Kastelein JJ; Geisel J; Real JT; Kuivenhoven JA; Miccoli R; Noseda G; Assmann G
Atherosclerosis; 1998 May; 138(1):25-34. PubMed ID: 9678768
[TBL] [Abstract][Full Text] [Related]
26. Probucol decreases apolipoprotein A-I transport rate and increases high density lipoprotein cholesteryl ester fractional catabolic rate in control and human apolipoprotein A-I transgenic mice.
Hayek T; Chajek-Shaul T; Walsh A; Azrolan N; Breslow JL
Arterioscler Thromb; 1991; 11(5):1295-302. PubMed ID: 1911715
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo interactions of Triton 1339 with plasma lipoproteins of normolipidemic rhesus monkeys. Preferential effects on high density lipoproteins.
Yamamoto K; Shen B; Zarins C; Scanu AM
Arteriosclerosis; 1984; 4(4):418-34. PubMed ID: 6431955
[TBL] [Abstract][Full Text] [Related]
28. Effects of testosterone replacement on HDL subfractions and apolipoprotein A-I containing lipoproteins.
Tan KC; Shiu SW; Pang RW; Kung AW
Clin Endocrinol (Oxf); 1998 Feb; 48(2):187-94. PubMed ID: 9579231
[TBL] [Abstract][Full Text] [Related]
29. Effect of bezafibrate on HDL with APO A-I and APO A-II and on HDL with APO A-I without APO A-II in hyperlipidaemic patients.
Branchi A; Rovellini A; Sommariva D
Int J Clin Pharmacol Res; 1995; 15(4):153-8. PubMed ID: 8871265
[TBL] [Abstract][Full Text] [Related]
30. Putative mechanisms of action of probucol on high-density lipoprotein apolipoprotein A-I and its isoproteins kinetics in rabbits.
Ying H; Saku K; Harada R; Takami N; Sasaki N; Saito Y; Arakawa K
Biochim Biophys Acta; 1990 Dec; 1047(3):247-54. PubMed ID: 2123720
[TBL] [Abstract][Full Text] [Related]
31. Mechanisms of high-density lipoprotein reduction after probucol treatment: changes in plasma cholesterol esterification/transfer and lipase activities.
Chiesa G; Michelagnoli S; Cassinotti M; Gianfranceschi G; Werba JP; Pazzucconi F; Sirtori CR; Franceschini G
Metabolism; 1993 Feb; 42(2):229-35. PubMed ID: 8474321
[TBL] [Abstract][Full Text] [Related]
32. Development of monoclonal antibodies for the selective isolation of human plasma apolipoprotein A-containing particles.
Calvo C; Bustos P; Sepulveda J; Ulloa N; Sepulveda V
Hybridoma; 1995 Dec; 14(6):603-8. PubMed ID: 8770650
[TBL] [Abstract][Full Text] [Related]
33. In vivo metabolism of apolipoprotein A-I on high density lipoprotein particles LpA-I and LpA-I,A-II.
Rader DJ; Castro G; Zech LA; Fruchart JC; Brewer HB
J Lipid Res; 1991 Nov; 32(11):1849-59. PubMed ID: 1770304
[TBL] [Abstract][Full Text] [Related]
34. Combined effects of pravastatin and probucol on high-density lipoprotein apolipoprotein A-I kinetics in cholesterol-fed rabbits.
Saku K; Liu R; Jimi S; Matsuo K; Yamamoto K; Yanagita T; Arakawa K
Jpn Circ J; 1995 May; 59(5):292-8. PubMed ID: 7596034
[TBL] [Abstract][Full Text] [Related]
35. [Pravastatin vs. probucol in the treatment of hypercholesterolemia. A double-blind study].
Sienra-Pérez JC; Lerman-Garber I; Ahumada-Ayala M; Castañón-Romo C; Cardoso-Saldaña G; Laguna-Castellanos M; Posadas-Romero C
Arch Inst Cardiol Mex; 1991; 61(4):365-73. PubMed ID: 1953212
[TBL] [Abstract][Full Text] [Related]
36. Effects of probucol on plasma lipids, lipoproteins and parameters of high density lipoprotein metabolism.
Wetterau JR; Combs KA; Albers HW; Lamkin G; Stein EA; Barnhart RL; Chi EM; Jackson RL; Harmony JA
Horm Metab Res; 1992 Jun; 24(6):289-96. PubMed ID: 1634195
[TBL] [Abstract][Full Text] [Related]
37. Structural and functional assessment of high-density lipoprotein heterogeneity.
Dobiásová M; Frohlich JJ
Clin Chem; 1994 Aug; 40(8):1554-8. PubMed ID: 8044996
[TBL] [Abstract][Full Text] [Related]
38. Very small apolipoprotein A-I-containing particles from human plasma: isolation and quantification by high-performance size-exclusion chromatography.
Nanjee MN; Brinton EA
Clin Chem; 2000 Feb; 46(2):207-23. PubMed ID: 10657377
[TBL] [Abstract][Full Text] [Related]
39. Characterization of human high-density lipoprotein subclasses LP A-I and LP A-I/A-II and binding to HepG2 cells.
Kilsdonk EP; Van Gent T; Van Tol A
Biochim Biophys Acta; 1990 Aug; 1045(3):205-12. PubMed ID: 2167131
[TBL] [Abstract][Full Text] [Related]
40. HDL subpopulations containing apoA-I without apoA-II (LpA-I) in patients with angiographically proven coronary artery disease.
Kuchta A; Strzelecki A; Ćwiklińska A; Gruchała M; Zdrojewski Z; Kortas-Stempak B; Wieczorek E; Gliwińska A; Dąbkowski K; Jankowski M
J Cardiol; 2017 Mar; 69(3):523-528. PubMed ID: 27169356
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
